Meningiomas are known to express somatostatin receptor 2 (SSTR2). PET using the SSTR2
analog 68Ga-DOTATATE has recently been introduced for imaging of meningiomas …

Background and purpose Meningiomas express the somatostatin receptor (SSTR), which
normal bone and brain lack. PET imaging with SSTR ligands such as 68 Ga-DOTATATE …

ABSTRACT BACKGROUND AND PURPOSE Meningiomas are the most common primary
intracranial tumors, typically treated with surgery and adjuvant radiation in cases of subtotal …

Background DOTATATE-based radionuclides have added new options in the diagnosis and
treatment of meningiomas; however, a reliable predictor of tumor growth has still not been …

Background Meningiomas express high levels of somatostatin receptor 2 (SSTR2). SSTR2-
targeted PET imaging with [68Ga]-DOTATATE can aid with distinguishing residual …

68Ga-DOTATATE PET/CT enables detection of meningioma tissue based on somatostatin
receptor 2 expression. Transosseous extension of intracranial meningiomas is known to be …

Abstract Multiple approaches with [68Ga]-DOTATATE, a somatostatin analog PET
radiotracer, have demonstrated clinical utility in evaluation of meningioma but have not been …

Purpose PET imaging with somatostatin receptor ligands, such as 68 Ga-DOTATOC, is a
well-established method for detection and target volume definition of meningiomas prior to …

Simple Summary [68Ga] Ga-DOTA-SSTR PET imaging has recently been introduced in the
management of patients with brain tumors, mostly meningiomas and pituitary adenomas or …

Background The prognosis of patients with progressive meningioma after failure of surgery
and radiotherapy is poor. Methods We retrospectively evaluated the safety and efficacy of …